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Genetic and biochemical defects of mitochondrial
function are a major cause of human disease, but
their link to mitochondrial morphology in situ has
not been defined. Here, we develop a quantitative
three-dimensional approach to map mitochondrial
network organization in human muscle at electron
microscopy resolution. We establish morphological
differences between human and mouse and among
patients with mitochondrial DNA (mtDNA) diseases
compared to healthy controls. We also define the
ultrastructure and prevalence of mitochondrial nano-
tunnels, which exist as either free-ended or connect-
ing membrane protrusions across non-adjacent
mitochondria. A multivariate model integrating mito-
chondrial volume, morphological complexity, and
branching anisotropy computed across individual
mitochondria and mitochondrial populations iden-
tifies increased proportion of simple mitochondria
and nanotunnels as a discriminant signature of mito-
chondrial stress. Overall, these data define the na-
ture of the mitochondrial network in human muscle,
quantify human-mouse differences, and suggest
potential morphological markers of mitochondrial
dysfunction in human tissues.INTRODUCTION
Mitochondria are multifunctional organelles that dynamically
transition from punctate structures to branched elongated tu-
bules within cells. Continuous changes in mitochondrial shapeThis is an open access article undarise through fission and fusion of mitochondria. Importantly, a
bidirectional relationship links mitochondrial shape and function
(Liesa and Shirihai, 2013; Picard et al., 2013a). Changes in mito-
chondrial shape in isolated cellular systems occur withinminutes
to hours and precede signaling events in model systems, influ-
encing skeletal muscle atrophy (Romanello et al., 2010), oxida-
tive stress (Shenouda et al., 2011; Yu et al., 2008), metabolic
sensing (Ramı´rez et al., 2017; Schneeberger et al., 2013), and
lifespan (Weir et al., 2017). This underscores the biological signif-
icance of mitochondrial morphology transitions for cellular and
organismal functions (Eisner et al., 2018) and emphasizes the
need to visualize and quantify mitochondrial shapes to gain
insight into the relevance of mitochondrial morphology for hu-
man health and disease.
One tissue that exhibits high energy consumption and con-
tains a large number of mitochondria is skeletal muscle. Building
on initial qualitative imaging revealing highly reticular mitochon-
drial networks in rodents (Bakeeva et al., 1978; Ogata and
Yamasaki, 1997) and live cell imaging approaches to quantify
mitochondrial morphology (Koopman et al., 2005), a quantitative
method was developed allowing quantification of mitochon-
drial size and shape in two dimensions (Picard et al., 2013b).
However, mitochondria exhibit complex three-dimensional
and anisotropic arrangement (i.e., different morphology when
measured in different orientation) in various cell types. This is
particularly salient in skeletal muscle, as subsequently described
in mice (Eisner et al., 2014; Glancy et al., 2015; Leduc-Gaudet
et al., 2015; Picard et al., 2013b), but the morphological 3D char-
acteristics of human mitochondria have not been described.
Consistent with their bacterial ancestry, mitochondria contain
their own genome, the mitochondrial DNA (mtDNA), which
encodes essential components of the respiratory chain and
oxidative phosphorylation (OXPHOS) system required for ATP
synthesis (Nicholls and Fergusson, 2013). Clinically, mtDNA mu-
tations have been widely implicated in human disease and agingCell Reports 26, 1–14, January 22, 2019 ª 2019 The Authors. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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lainen and Battersby, 2018). In cellular and animal models,
mtDNA mutations (Koopman et al., 2010; Picard et al., 2014),
impaired Ca2+ handling (Eisner et al., 2017), and disrupted mito-
chondrial dynamics due to autosomal defects in the fusion-
fission components (Ranieri et al., 2013) all perturbmitochondrial
morphology. Furthermore, in human skeletal muscle fibers,
mtDNA mutations that compromise mitochondrial energy pro-
duction are also associated with ultrastructural abnormalities in
mitochondrial cristae organization (Vincent et al., 2016), sug-
gesting that mitochondrial morphology and function are also
linked in vivo. However, the quantitative relationship between
mtDNA defects, mitochondrial morphology, and mitochondrial
organization in human disease remains unclear.
To clarify this relationship, we developed a quantitative
approach to analyze 3D skeletal muscle mitochondrial network
organization at single organelle resolution in human muscle bi-
opsies. We provide quantitative analysis of mitochondrial
morphology in human muscle, perform a comparative mouse-
human analysis, and evaluate the effect of mtDNA mutations in
patients with genetically confirmed primary mtDNA mutations
on morphological parameters. We also use a combination of
multivariate analyses to identify key mitochondrial morphology
characteristics of the myopathic mitochondrial network,
providing a foundation to examine and monitor anomalies in
muscle mitochondrial networks.
RESULTS
We imaged biopsy specimens from healthy volunteers (n = 8) by
serial block face scanning electron microscopy (SBF-SEM). The
resolution achieved here with SBF-SEM is 10 nm in the x/y plane
and 30 nm in the z plane, which typically enables visualization of
individual cristae membranes. This is inferior to conventional
transmission EM imaging but superior to other three-dimen-
sional light-based imaging methods (Dahl et al., 2015; Eisner
et al., 2014; Picard et al., 2013b). Because our objective was
to establish the morphology of individual mitochondria within
the skeletal muscle network, we opted for a method with
sufficient resolution to resolve closely juxtaposed (approxi-
matelyR 20 nm) membranes, which is critical to avoid merging
immediately adjacent organelles with distinct outer mitochon-
drial membranes (Figure S1).
To test our approach in human skeletal muscle, we first
analyzed coexisting mitochondrial sub-populations known to
markedly differ in both morphology and function (Ferreira et al.,
2010; Picard et al., 2013b). The subsarcolemmal (SS) mitochon-
dria reside beneath the plasma membrane, often in proximity to
myonuclei (i.e., perinuclear) and capillaries (i.e., perivascular)
(Glancy et al., 2014), and are generally globular in morphology,
with few branches. On the other hand, the intermyofibrillar (IMF)
mitochondria are located between myofibrils arranged in pairs
at the z-band of each sarcomere (Vendelin et al., 2005) and have
elongated tubular shapeswhen imaged in2Dalong the transverse
plane of the muscle in rodents (Figure 1A; Picard et al., 2013b).
For each region of interest, 400 serial images were captured at
30 nm intervals in the transverse orientation (Figure 1B; Video
S1). Approximately 50 individual SS or IMF mitochondria were2 Cell Reports 26, 1–14, January 22, 2019manually traced from each image stack and 3D reconstructions
generated. In all human and mouse fibers analyzed, the mito-
chondrial network was found not to be a single reticulum. Rather,
the mitochondrial network is composed of largely distinct organ-
elles rarely reaching beyond a few microns in length in either
direction, with the highest density of mitochondria at each of
the sarcomeric planes (Video S1; Figure 1C). Reconstructions
also confirmed that SS mitochondria tend to be globular and
possess branches only where they project into the IMF space
(Video S2), representing possible sites of physical interactions
or their migration toward the IMF compartment.
Establishing Quantitative Metrics of Three-Dimensional
Shape Complexity and Branching Direction
To determine whether mitochondrial shapes significantly differ
between cells, individuals, species, and in response to mtDNA
defects, a quantitative measure of morphological complexity is
required. We therefore adapted the two-dimensional metric
known as form factor (FF) (Koopman et al., 2005) to a three-
dimensional metric of mitochondrial shape complexity. We call
this the mitochondrial complexity index (MCI; see STAR
Methods for details). The MCI is analogous to sphericity and
scales with mitochondrial shape complexity, including branches
and increased surface area relative to volume. Simulations on
basic 3D models confirmed that MCI is insensitive to mitochon-
drial volume, such that mitochondria of the same shape but of
different volumes have the same MCI (Figure S2).
Because mitochondria exchange molecular information with
each other via fusion (Chen et al., 2010), a process that could in-
fluence the spread of mtDNA defects along mitochondrial
branches in genetic mitochondrial disease, we also sought to
develop a method to assess mitochondrial branching in either
the transverse (i.e., across the muscle fiber) or longitudinal (i.e.,
along the fiber) orientation (Figures S3A and S3B). The ratio of
quantified transverse/longitudinal branching yielded the mito-
chondrial branching index (MBI) (Figure 1E). Mitochondria with
equal branching in both orientations have an MBI of 1; those
with greater branching in the transverse plane score > 1,
and those more branched along the length of the muscle
fiber score < 1 (Figure 1F). Together, the MCI and MBI repre-
sent quantitative metrics to evaluate individual mitochondrial
morphology in healthy humans, across species, and in disease.
Biopsy to Fixation Delay Does Not Impact Mitochondrial
Morphology
Gaining the most clinically relevant insights into human cell bio-
logical processes requires the study of human tissues, but there
are limitations associated with clinical studies. In live cultured
cells and ex vivo, mitochondria undergo fusion events within
minutes (Eisner et al., 2014) and morphology transitions occur
in seconds to minutes (Liu et al., 2009). Therefore, it is conceiv-
able that mitochondrial morphology would shift during the delay
necessarily encountered between the biopsy of human muscle
and subsequent fixation. To directly test this possibility, we
compared muscle mitochondrial morphology when it was either
(1) fixed in vivo without any delay via transcardial perfusion or (2)
fixed by immersion following a 1 h post-mortem delay, in the
mouse tibialis anterior (Figure 2). SBF-SEM image stacks were
Figure 1. Imaging and Quantitative Analysis of Mitochondrial Morphology and Volume in IMF and SS Mitochondrial Subpopulations in
Human Skeletal Muscle
(A) Electron micrograph of human skeletal muscle in transverse (i.e., cross section) orientation. A single cell is highlighted (yellow), with corresponding higher
magnification images of intermyofibrillar (IMF) and subsarcolemmal (SS) mitochondria. Note the difference in morphology between IMF and SS mitochondrial
sub-populations.
(B) Z stack at EM resolution from serial block face scanning electron microscopy (SBF-SEM) used for 3D reconstructions. See Video S1 for animation. Total
imaging depth is 12 mm.
(C) The humanmitochondrial network was reconstructed and shown here in transverse (top view) and longitudinal (side view) orientations. Eachmitochondrion is
a different color.
(D) The spectrum of human IMF and SS mitochondrial shapes and volumes, ranked left to right from smallest to largest.
(E) Schematic of a skeletal muscle fiber and the different sarcomeric planes. The mitochondrial branching index (MBI) is used to quantify the relative branching in
the transverse and longitudinal orientations. Trans, transverse; Long, longitudinal.
(F) Two reconstructed mitochondria from SBF-SEM seen in both transverse and longitudinal orientations. The orange mitochondrion (left) is longer and more
branched in the longitudinal orientation of the muscle fiber (i.e., columnar), whereas the red mitochondrion (right) is more extensively branched in the transverse
orientation (i.e., in cross section). This branching anisotropy is captured by each mitochondrion’s MBI value.
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Three-dimensional reconstructions showed no significant dif-
ference between fixation methods (Figure 2A). Complex shaped
mitochondria with branches >1 mm in length could be observed
in equal abundance with both immediate and delayed fixation.
Likewise, neither mitochondrial volume nor MCI values differed
significantly across fixation conditions (Figures 2B and 2C),demonstrating that fixation delay does not result in loss of
morphological complexity within an hour ex vivo. These results
demonstrate that the mitochondrial network organization can
be studied in fixed biopsy specimens.
Mouse and Human Mitochondrial Morphology Differ
Qualitatively, the 3D human mitochondrial network (Figure 1C)
appeared less interconnected than previous reports haveCell Reports 26, 1–14, January 22, 2019 3
Figure 2. Mitochondrial Morphology Differs between Healthy Humans and Mice
(A) Electron micrograph and 3D reconstruction of mitochondria in mouse tibialis anterior muscle. Muscle was fixed in two ways: by immersion after a delay at
room temperature (left) and via transcradial perfusion without delay (right). Scale bars, 1 mm.
(B and C) IMF mitochondrial volume (B) and MCI (C) in mouse muscle fixed by transcardial perfusion (orange) and immersion (pink) fixation shown as cumulative
frequency distributions. Each line represents data from 150 mitochondria sampled across 3 muscle fibers in each animal. n = 3 mice per group.
(D) Mitochondrial volume and (E) MCI in healthy humans (blue) and mice (orange) shown as cumulative frequency distributions. n = 6 mice and 8 humans.
(F) Average MCI for human and mouse IMF mitochondria. Data are means ± SEM; n = 875 in mouse and 1,180 in humans, linear mixed model.
(G) Bivariate plot of volume and MCI for healthy human controls (blue) and mice (orange). Each point represents a single mitochondrion.
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morphology had not previously been quantified and com-
pared across mouse and human. We therefore quantified
mitochondrial volume and MCI in parallel from both species.
Mitochondrial populations were analyzed using cumulative
frequency distributions that illustrate the relative abundance of
mitochondria with different volume or MCI values (Figures 2D
and 2E).
Mouse IMF mitochondria were 144.0% larger on average
than in healthy humans (p = 0.0019) (Figure 2F) but did not
differ on average in MCI (p = 0.69) (Figure 2G). In mice, the
top 10% largest mitochondria had an average volume of
4.19 mm3, compared to only 0.68 mm3 for human mitochondria.
Similarly, SS or perinuclear mitochondria were on average
412.0% larger (p < 0.0001) but also 31.0% less complex
(p = 0.014) compared to those in healthy humans (Figure S4).
Thus, mitochondrial volume, and to a lesser extent the
complexity of SSmitochondria, differ significantly differ between
mouse and human.4 Cell Reports 26, 1–14, January 22, 2019Intermyofibrillar Mitochondria Are More Complex than
Subsarcolemmal Mitochondria
In healthy human muscle, volume for SS and IMF mitochondria
were relatively similar. IMF mitochondria were on average
77.2% larger than SS mitochondria (p < 0.0001), largely due to
a lower proportion of small IMFmitochondria (Figure 3A). In com-
parison, the MCI for human IMF mitochondria was 118.0%
greater than for SS mitochondria (p < 0.0001), a difference
largely attributable to a substantial proportion of highly complex
IMF mitochondria, and a complete absence of SS mitochondria
with MCI > 7.5 (Figure 3A).
The MCI population distribution also showed a higher level of
kurtosis and skewness (kurtosis = 37.09, skewness = 4.88,
n = 1201) for IMF mitochondria than for SS mitochondria (kurto-
sis = 27.14, skewness = 4.02, n = 344), possibly suggesting
the existence of structural or other factors that constrain
morphology, particularly in the IMF compartment.
SS mitochondria in patients with mitochondrial disease were
on average 147.0% larger than those in healthy controls
Figure 3. Natural Variation in Mitochondrial Volume and Complexity in Healthy Human Skeletal Muscle
(A) Population distribution of mitochondrial volume and MCI in control human muscle shown as cumulative frequency distributions for SS and IMF mitochondria.
Insets: mean values ± SEM; n = 346 for SS and 1,180 for IMF, linear mixed model. (Right) Representative 3D reconstructions of mitochondrial subpopulations.
(B) Example 3D reconstructions of two muscle cells from the same person (Control 1).
(C and D) Cumulative population distributions of mitochondrial volume (C) and MCI (D) in three muscle fibers from Control 1, and (inset) with means ± SEM for
each cell. Each line represents 50 IMF mitochondria from a single muscle cell.
(E) Example 3D reconstructions from muscle fibers from two different individuals (Controls 1 and 2) illustrating between-person (i.e., inter-individual) differences.
(F and G) Cumulative frequency distribution demonstrating between-person variation in volume (F) and MCI (G) in 8 healthy individuals. Each line represents 150
IMF mitochondria sampled across 3 muscle fibers for each person.
(H and I) Coefficient of variation (C.V.) for volume (H) andMCI (I) in healthy controls (C) and patients (P). C.V. values are shown between mitochondria within single
cells (n = 18–24 cells), between themean values across fibers (n = 6–8 individuals), and between-person across healthy control andmito disease groups (n = total
of 1,180 and 900 IMF mitochondria in controls and patients, respectively). Data shown are mean ± SEM.
(J) Karyotype-like arrangement of 50 individual reconstructed IMF mitochondria from a single muscle fiber of patient 5 (asymptomatic sister with m.8344A>G),
from the lowest to the highest MCI (left to right).
See Figure S4 for larger version and Video S3 for an animation of the source muscle fiber.
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(p = 0.50). Because the IMF compartment is the predominant
compartment in muscle fibers, and given previous work showing
that IMF are more responsive than SSmitochondria to metabolic
perturbations such as exercise (Picard et al., 2013b), aging
(Leduc-Gaudet et al., 2015), and metabolic oversupply (Picard
et al., 2015a), we focused the remainder of our analyses on
IMF mitochondria.
Next, we determined the degree of variation in IMF mitochon-
drial volumeandMCI at different levels: (1) betweenmitochondria
within single muscle fibers, (2) between fibers of a given individ-
ual, and (3) between different individuals (Figures 3B–3I). Varia-
tion in mitochondrial volume and MCI within muscle fibers of
healthy controlswas highestwith an estimated coefficient of vari-
ation (C.V.) ranging from 56% to 243% for volume and from 34%
to 131% for MCI. Standard deviation determined from linear
multi-level models showed similar results for both volume (SD =
0.81) and MCI (SD = 0.68). These numbers illustrate the remark-
able population heterogeneity and diversity of 3D mitochondrial
volumes and shapes within human muscle fibers. The diversity
of a cell’s IMF mitochondria is illustrated in a mito-otype (Fig-
ure 3J)—the mitochondrial equivalent to a karyotype of nuclear
chromosomes (see Figure S5 for full size rendering).
Comparatively, differences in mean volume and MCI between
muscle fibers of a given individual were more limited, with cell-
to-cell C.V. ranging from 21% to 32% for volume and 14% to
65% for MCI (Figures 3B–3D). Again, standard deviation yielded
a similar result for both volume (SD = 0.14) and MCI (SD = 0.26).
Variability between healthy controls was surprisingly large and
most pronounced for MCI (Figures 3E–3G). When combining
all cells together and comparing the averages between individ-
uals, the C.V. was 38% for volume (Figure 3H) and 59% for
MCI (Figure 3I) and had a SD of 0.28 for volume and 0.43 for
MCI. These data establish that considerable intra- and inter-indi-
vidual differences exist in mitochondrial size and morphological
complexity in humans, with variability in both volume and MCI
being highest intracellularly (among mitochondria of a given
cell), and lowest between cells of a given person.
Interestingly, the within-person variation in MCI was approxi-
mately two times greater than for volume (SD = 0.26 versus
0.14; Mann-Whitney, p < 0.0001). Moreover, the average MCI
across muscle fibers of a given individual varied by as much as
65%, a phenomenon likely attributable to the mixed muscle fiber
composition in human muscle (Gouspillou et al., 2014), which
show different mitochondrial properties (Mishra et al., 2015).
The greater variation in MCI than in volume also suggested that
morphological complexity may be more sensitive to biochemical
deficiency and inter-individual differences than volume. There-
fore, we mainly focused our subsequent analyses on MCI.
Patients with mtDNA Defects Have More ‘‘Simple’’
Fragmented Mitochondria than Healthy Controls
We studied six patients with mtDNA disease including: single,
large-scale mtDNA deletion (n = 2), m.8344A>G tRNALys
(n = 3), and m.3243A>GLeu(URR) (n = 1) (Table S1). These are
among themost common disease-causingmtDNA defects (Gor-
man et al., 2015). As in healthy controls, MCI showed substantial
intra- and inter-individual variability in patients with mitochon-6 Cell Reports 26, 1–14, January 22, 2019drial disease (Figure 4). The within fiber C.V. for MCI was 11%–
170% (SD = 0.69), similar to controls (p = 0.72). In general,
mitochondrial MCI and volume for patient mitochondria fall
within the upper and lower limits of healthy controls, with a sub-
set of fibers having a lower range in MCI values (Figure S6, e.g.,
patients 2 and 4).
Compared to healthy controls, mitochondria in patients were
on average 39.6% less complex (p = 0.036) (Figure 4A). How-
ever, the MCI population distributions differed considerably in
the abundance of ‘‘simple’’ (below the 10th percentile of the con-
trol population) or ‘‘complex’’ (above the 90th percentile of the
control population) mitochondria. Mitochondria exist as func-
tionally interconnected populations and only a portion of the
overall population may respond to bioenergetic perturbations
(Saunders et al., 2013). To capture these changes, we quantified
the proportion of simple and complex mitochondria as shown in
Figure 4B. Except for patient 2 who had a similar proportion of
simple mitochondria as controls (9.33% versus 10%), 46% of
mitochondria in patients with mtDNA defects were simple. This
represents a 3.6-fold elevation in the proportion of simple mito-
chondria relative to healthy controls (Figures 4C and 4D).
Mitochondrial Volume Density Does Not Account for
Differences in MCI
MCI differences could theoretically be accounted for by variation
in the overall density ofmitochondriawheremore densely packed
mitochondria may have more interconnections. We therefore
measured mitochondrial volume density, defined as the percent-
age of muscle fiber volume occupied by mitochondria, in 3D re-
constructed models over two full sarcomeres. Mitochondrial vol-
ume density was elevated in two patients but on average was not
significantlydifferent betweenpatients (4.0%)andcontrols (2.6%)
(p = 0.534) (Figure 4E). Across controls and patients, volume den-
sity was also not related to average MCI within a cell (Pearson
r2 = 0.097, p = 0.19), which excluded the possibility that differ-
ences inMCIwere driven bymitochondrial volumedensity. Taken
together, these data from healthy controls and patients withmito-
chondrial disease demonstrate that mitochondrial dysfunction
due tomtDNAmutations is associatedwith a shift inmitochondrial
complexity independent of mitochondrial volume density.
The Mitochondrial Network Is Anisotropic
MCI is agnostic to the orientation of individual mitochondria
within the skeletal muscle fiber. However, clonally expanded
mtDNA defects are thought to progress longitudinally along
muscle fibers (Bua et al., 2006; Campbell et al., 2014) and we
have recently reported that mtDNA dysfunction appears to pref-
erentially spread in the transverse orientation prior to longitudinal
propagation (Vincent et al., 2018). One potential mechanism for
the cytoplasmic propagation of mtDNA mutations is the trans-
mission of mtDNA molecules through fused mitochondria within
the network. However, the relative connectivity of mitochondria
in either transverse and longitudinal orientations, or mitochon-
drial ‘‘anisotropy,’’ has not previously been defined.
Mitochondria are organized at z-bands and occasionally
extend in the longitudinal orientation to span a full sarcomere
(see Video S3). In healthy controls, 3.3% of mitochodnria
spanned a full sarcomere, compared to 4.9% (p = 0.07) in
Figure 4. IMF Mitochondrial Volume and MCI in Patients with mtDNA Disease
(A) Cumulative frequency distribution for MCI in combined healthy controls and patients. Each line in the patients represents 150 IMF mitochondria across 3
muscle fibers. Inset shows mean ± SEM for each person. Controls (n = 8) combined n = 1180 mitochondria.
(B) Schematic illustrating ‘‘simple’’ and ‘‘complex’’ mitochondria defined as the 10th and 90th percentile of the control population distribution, respectively (shaded
yellow regions).
(C) Proportion of IMF mitochondria with MCI values that fall below the 10th (simple) or above the 90th (complex) percentiles of the control population for healthy
controls (black) and patients 1–6 with mitochondrial disease.
(D) Bivariate plot of MCI and volume for all healthy control IMF mitochondria (blue, n = 1,180) and mitochondrial disease (green, n = 900). Each data point
represents a mitochondrion. Dotted lines denote the 10th and 90th percentiles of the control population. Simple mitochondria include 10% of mitochondria in the
healthy controls and 46% in patients (blue shading). Large mitochondria include 10% of mitochondria in controls and 14% in patients (orange shading).
(E)Mitochondrial volume density calculated as the proportion ofmuscle volume occupied bymitochondria. n = 8 controls and 6 patients, Mann-Whitney test, N.S.
Data shown are mean ± SEM.
(F) Mitochondrial branching index (MBI = Cross sectional ranching indicator/Longitudinal branching indicator) in combined controls (n = 973 IMF mitochondria),
patients (n = 896) and mice (n = 839). Note that the number of mitochondria that are more branched cross sectionally (red) is greater than those more branched
longitudinally (purple) in all three groups. Image stacks with imperfect orientation precluded reliable analyses of branching orientation for some mitochondria,
which were excluded, explaining the lower total number of mitochondria quantified here.
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muscle contains a significantly larger fraction of columnar mito-
chondria that extend in the longitudinal axis, resulting in 18.9%of
organelles spanning at least one sarcomere.
To precisely quantify the degree of mitochondrial connectivity
in different orientations, we computed theMBI (see Figure 1E) for
all IMF mitochondria. In healthy controls, approximately half
(50.6%) of mitochondria were equally branched in both direc-
tions (Figure 4F). However, there were 4.4 times more mito-
chondria that are more extensively branched in the transverse
orientation (40.4%) compared to the longitudinal orientation
(9.1%) (Figure 4F). In mitochondrial disease, a similar percentage
(51.0%) mitochondria were equally branched in both directions
and a smaller fraction (36.2%) exhibited more branching in the
transverse orientation (Figure 4F). Together, these data show
that mitochondrial network connectivity across the plane ofeach z-band is approximately 4-fold greater than connectivity
along the muscle fibers (see complete 3D reconstructions in
Video S3) and that mtDNA defects may promote transverse
mitochondrial branching within individual sarcomeric planes.
We next determined whether branching direction differed be-
tween humans and mice. Compared to healthy humans, mice
had a smaller (30.2%) proportion of mitochondria equally
branched in both orientations, and more mitochondria with
extensive branching in both the transverse (54.7%) and longitu-
dinal (15.1%) orientations. Mice have significantly more mito-
chondria with predominant branching in transverse (54.7%
versus 40.4%, 1.35-fold of controls) and longitudinal (15.1%
versus 9.1%, 1.66-fold) orientations than human mitochondria
(Figure 4F). These quantitative data demonstrate that mouse
skeletal muscle harbors a substantially different mitochondrial
connectivity pattern than human muscle.Cell Reports 26, 1–14, January 22, 2019 7
Figure 5. Variability in Mitochondrial Morphology in Three Family Members with Variable Levels of the m.8344A>G Mutation
(A) Pedigree of three related female patients. Patient 3 (orange): the proband with 97% heteroplasmy, 97% COX-deficient muscle fibers, and severe myopathy
and exercise intolerance; patient 4 (blue): the affected mother with 63% heteroplasmy, 22% COX-deficient muscle fibers, and mild myopathy; and patient 5
(green): the unaffected sister with 40% heteroplasmy and some intermediate COX-deficient fibers. The sisters are of comparable age but have inherited different
levels of mtDNA mutation.
(B–D) Single representative section from SBF-SEM and reconstruction of 50 IMFmitochondria in muscle fibers for of patients 4 (B), 3 (C), and 5 (D). Note the small
fragmentedmorphology in the proband andmother (B and C) and a high number of branchedmitochondria in the unaffected sister, who has intermediate mtDNA
mutation load (D). Scale bars, 1 mm.
(E) Proportion of simple and complex IMFmitochondria (based on the 10th and 90th percentiles of the MCI distributions in healthy controls) for patients 3, 4, and 5
compared to the healthy individuals. ND, no detectable complex mitochondria.
(F) Bivariate plot of MCI and mitochondrial volume in the three individuals with the m.8344A>G mutation. Shaded areas illustrate the mitochondrial population
distribution for each patient. Each data point is a mitochondrion (n = 150 per individual).
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Within the group of patients with mitochondrial disease studied
here, we had the opportunity to study samples from a trio of
genetically related patients with the m.8344A>G tRNALys muta-
tion (Figure 5A, Videos S4, S5, and S6). The mother (patient 4)
was 50 years old with 63% mutation load and showed a mild
myopathy. Her eldest daughter (patient 3) was 22 years old,
with skeletal muscle mutation load of 97%, severe myopathy,
and exercise intolerance. In comparison, her younger daughter
(patient 5) was 20 years old with only 40% mutation load in the
muscle andwas clinically asymptomatic. Given the genetic relat-
edness of these individuals, the similar age of the sisters, and the
markedly different mtDNA heteroplasmy between them, this pro-
vided an opportunity to evaluate the association between
mtDNA mutation load and mitochondrial morphology.8 Cell Reports 26, 1–14, January 22, 2019The 3D reconstructions for all three patients showed dramatic
differences associated with heteroplasmy. Both the mother
(patient 4) and the most severely affected daughter (patient 3)
had the highest level of ‘‘simple’’ fragmented roundedmitochon-
dria in this cohort: 71.3% and 78.7% of all mitochondria, respec-
tively, compared to 10% in controls (Figures 5B and 5C, Videos
S4 and S5). This is in sharp contrast to mitochondrial network
architecture in healthy controls and in the unaffected sister
(patient 5; Figure 5D and Video S6), the latter showing a large
number of complex mitochondria.
The unaffected sister (patient 5, 40% heteroplasmy) was the
only member of the family to have any complex mitochondria
(7.3%), many of which had very high MCI values reflecting
extensive branching and nanotunnels (Figure 5E). This patient
also had 2.6 times more small mitochondria than controls, re-
sulting in substantial heterogeneity of both MCI and volume
Figure 6. Prevalence and Anatomy of Mitochondrial Nanotunnels in Human Skeletal Muscle
(A) Transmission Electron Microscopy of skeletal muscle from patient 5, with mitochondria harboring nanotunnels (pseudocolored blue). Arrows indicate
nanotunnel shafts.
(B and C) Image stack from SBF-SEM (B) and three-dimensional reconstruction (C) of a mitochondrion with two nanotunnels (arrows). Slice thickness is 30 nm.
(D) Frequency of nanotunnels per 100 mitochondria in healthy controls and individuals with mtDNA disease. All controls (n = 8) were compared to all patients
(n = 6), n = 399 nanotunnels, Mann-Whitney.
(E and F) A mitochondrion with two nanotunnels reconstructed in Microscopy Image Browser (E) and schematic illustrating the measurements of nanotunnel
anatomy obtained from 3D reconstructions (F). The internal diameter is derived from the external diameter (see I).
(G and H) Frequency distribution of nanotunnel length (G) and diameter (H) as assessed from reconstructions measured in Amira (n = 362). Distributions are
positively skewed.
(I) Frequency distribution of minimum estimated lumen diameter for each nanotunnel measured by subtracting distances for the combined thickness of the inter-
membrane space, OMM, and IMM from the measured external diameter. The red dotted line indicates the estimated dimension of mtDNA nucleoids (based on
bovine heart high-resolution imaging; Kukat et al., 2011). Inset: proportion of mitochondrial nanotunnels whose lumens are >110 nm, indicating the theoretical
proportion of nanotunnels that could potentially house or transport nucleoids (right of red dashed line). Estimates based on n = 362 nanotunnels.
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Mitochondrial Nanotunnels Are More Frequent in
Patients than Controls
Mitochondrial nanotunnels are thin double membrane projec-
tions of both outer (OMM) and inner (IMM) mitochondrial mem-
branes connecting two non-adjacent mitochondria and capable
of transporting proteins between connected organelles (Figures
6A–6C; Eisner et al., 2014, 2017; Vincent et al., 2017). There is no
previous systematic analysis of nanotunnel size and frequency in
human tissues.
Using SBF-SEM, we identified nanotunnels in both the trans-
verse and longitudinal orientation. In healthy controls, therewas on average 2.1 nanotunnels per 100 mitochondria (Fig-
ure 6D). In comparison, patients with mitochondrial disease
showed an average of 38 nanotunnels per 100 mitochondria,
representing an 18.1-fold greater frequency (p < 0.01) (Fig-
ure 6D). It should be noted that patients 3 and 4 (the mother
and eldest daughter with m.8344A>G mutation), despite
exhibiting a massively fragmented mitochondrial network, still
had an equal or greater nanotunnel frequency than most
controls.
Mitochondrial nanotunnels can exist in two forms: as free-
ended membrane protrusions arising from a donor mitochon-
drion or as connecting nanotunnels joining two mitochondria
(Vincent et al., 2017). Of the 399 nanotunnels analyzed in
mtDNA disease biopsies, 19.0% were free-ended membraneCell Reports 26, 1–14, January 22, 2019 9
Figure 7. Multivariate Analysis Mitochondrial Morphological Signatures among mtDNA Disease and Healthy Controls
(A) Partial least-squares discriminant analysis (PLS-DA) on mtDNA disease patients (n = 6) and healthy controls (n = 8) with 95% confidence intervals (shaded
areas). The 2-component model illustrated explains 46% of the variance in the dataset and produces partial group separation.
(B) Variable importance in projection (VIP) scores illustrating the contribution of different morphological features to the separation of healthy controls and patients
in the PLS-DA model. Parameters with scores above 1 (red dotted line) are considered significant. Morphological features with higher values in mitochondrial
disease are in green, those higher in healthy controls are in blue. Support vector machine (SVM) yielded similar results (not shown).
(C) Bi-variate plot of the top two parameters, nanotunnels per 100mitochondria and the proportion of simplemitochondria. Collectively, in this limited sample, this
combination of measures represents a signature sufficient to accurately distinguish healthy controls (blue) and patients with mtDNA disease (green).
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We then determined their dimensions withmeasurements per-
formed in Amira from high-resolution 3D reconstructions gener-
ated in microscopy image browser (MIB) (Figures 6E and 6F).
Previous estimates of human mitochondrial nanotunnel dimen-
sions were solely based on 2D single-plane transmission EM
images (Vincent et al., 2017). Here, human skeletal muscle nano-
tunnels ranged from 64.9 nm to 2.0 mm in length (Figure 6G). The
external diameters ranged from 26.1 to 204.2 nm (Figure 6H),
dimensions similar to mitochondria-derived vesicles (Cadete
et al., 2016; Soubannier et al., 2012).
To determine whether mitochondrial nanotunnels could theo-
retically transport mutant mitochondrial nucleoids or exhibit
cargo selectivity, we estimated the smallest nanotunnel matrix
lumen, which would theoretically limit the diffusion of macromol-
ecules. We measured the smallest external diameter for each
nanotunnel and subtracted 24 nm (8 nm for each the intermem-
brane space, plus 2 nm for OMMand IMM,multiplied by 2 sides).
The distribution of estimated nanotunnel lumen size ranged from
2.1 to 180.2 nm (Figure 6I)—almost two orders of magnitude.
Given that nucleoids are believed to be approximately 110 nm
in size (Kukat et al., 2011), this limited structural evidence sug-
gests that only 4.1% of nanotunnels measured in human muscle
would bewide enough to allow the transport ofmtDNApackaged
as nucleoids. This point is in definite need of empirical validation.
Key Mitochondrial Morphological Features Can
Distinguish Patients from Controls
Finally, we sought to determine whether there are consistent
mitochondrial morphological features that differentiate healthy
controls from patients with mitochondrial disease. To test this
hypothesis in an unbiased manner, we assembled a list of
morphological features extracted from single mitochondria and10 Cell Reports 26, 1–14, January 22, 2019population distributions, including the percentage of simple,
complex, small, and large mitochondria (as described above),
median MCI and volume, mitochondrial volume density, and
mitochondrial nanotunnel frequency.
We used partial least-squares discriminant analysis (PLS-DA)
to integrate morphological parameters into a single multivariate
model that aims to maximize group differences (healthy controls
versus mitochondrial disease). The model captured 46% of the
total variance in the dataset and achieved partial separation of
controls and patients with a small degree of overlap in the 95%
confidence intervals (Figure 7A). Rank ordering of the variable
importance in projection (VIP) scores for each parameter identi-
fied the most important morphological features that discriminate
betweenhealthy controls andmitochondrial disease. The top two
features were (1) the abundance of nanotunnels and (2) the pro-
portion of simple mitochondria (Figure 7B). As a validation of
this result, the same two features were identified using another
machine learning-based classifier, support vector machine
(SVM), which similarly classifies data into two groups and pro-
vides estimates for the importance for each variable in the model
(Ben-Hur et al., 2008). Plotting together the percentage of simple
mitochondria against the abundance of nanotunnels resulted in
complete segregation of healthy controls and patients (Fig-
ure 7C). These analyses, albeit underpowered, suggest that a
high proportion of morphologically simple mitochondria com-
bined with numerous nanotunnels may represent a signature of
mitochondrial OXPHOS deficiency or mitochondrial stress.
DISCUSSION
The morphology of mitochondria is intrinsically linked to their
function, with numerous studies finding correlations between
metabolic perturbations, mitochondrial morphology, mitochon-
drial function, and tissue functions in model organisms (Gomes
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et al., 2014; Trushina et al., 2012). Here we developed three-
dimensional shape metric, the MCI, and validated it against
known differences between skeletal muscle SS and IMF mito-
chondria. Using a combination of imaging and computational
methods, we have provided quantitative three-dimensional anal-
ysis of human mitochondria and established differences in mus-
cle mitochondrial morphology between human and mouse and
between healthy controls and patients with primary mtDNA
disease.
Previous three-dimensional reconstruction of human skeletal
muscle mitochondria had been limited to one study using
focused ion beam (FIB)-SEM in healthy individuals (Dahl et al.,
2015), which did not quantify individual mitochondria. Another
study using FIB-SEM also provided an assessment of mouse
skeletal muscle mitochondrial morphology suggesting the exis-
tence of a highly connected mitochondrial reticulum (Glancy
et al., 2015). Our analyses extend these findings in several ways.
Quantitative assessment of individual mitochondrial mor-
phology in healthy human muscle fibers demonstrated an unex-
pectedly large degree of variability within each cell, between
cells of the same individual, and between individuals. As ex-
pected, given that muscle fiber types with different oxidative
capacity exhibit different mitochondrial morphology and dy-
namics (Dahl et al., 2015; Mishra et al., 2015), the variation in
MCI between muscle fibers and between individuals was sub-
stantial. It is not currently possible to assess muscle fiber types
on electron microscopy samples. Here, muscle fibers were
selected based on high mitochondrial mass, so the analyses
likely include a mixture of different oxidative fiber types. In pa-
tients with mitochondrial disease, cell-to-cell heterogeneity
could be further enhanced by the heterogenous distribution of
mtDNAmutation load presenting as a mosaic pattern of affected
(OXPHOS-deficient) and unaffected (OXPHOS-normal) fibers
(Rocha et al., 2015). Using the present technique, the correlation
with single-cell heteroplasmy, respiratory chain function, and fi-
ber type is not possible and remains a challenge for future
studies to address. Nevertheless, even in analyses of single
muscle fibers, IMF mitochondrial volume, complexity, and
branching showed high heterogeneity—with simple and com-
plex, and small and large mitochondria coexisting within the
same cells. It is noteworthy that moderate mtDNA heteroplasmy
in mitochondrial disease was associated with greater heteroge-
neity, as expected from having some mitochondria with mutant
mtDNA and some with wild-type (i.e., normal) mtDNA. Together,
these data document the natural heterogeneity of the human
mitochondrial network, which by itself may represent a relevant
outcomemeasure andmay have functional implications in health
and disease.
When comparing mouse and human muscle fibers, our data
show that species differences are more pronounced for volume
than for morphological complexity. Mitochondria in mice tend to
be columnar, extending in the longitudinal orientation, with
frequent small transverse protrusions similar to that reported
previously (Glancy et al., 2015). Glancy et al. (2015) reported
the mitochondrial network in oxidative mouse muscle fibers to
constitute an almost completely continuous reticulum. In
contrast, our analyses inmousemuscle reveal numerous distinctmitochondria are tightly packed into columns between myofi-
brils. These mitochondria frequently have immediately adjacent
outer mitochondrial membranes and inter-mitochondrial junc-
tions (IMJs) (Picard et al., 2015b). When visualized with sufficient
resolution, these juxtaposed mitochondria are physically distinct
organelles with separate matrix spaces (see Figure S1). Molecu-
lar information is certainly transferred between mitochondria un-
der specific cellular states (Glancy et al., 2017; Kurz et al., 2010;
Picard et al., 2015b). Nevertheless, rather than establishing con-
tinuity by proximity, in an effort tomap themorphology of individ-
ual mitochondria, here we established segmentation criteria
where each mitochondrion is defined as having a continuous
outer membrane. The current approach reflects the anatomy
and nature of individual mitochondria as ultimately determined
by processes of fusion and fission. Moreover, immediately adja-
cent mitochondria can exhibit localized and isolated depolariza-
tion and ‘‘flash’’ events (Hou et al., 2014), establishing individual
adjacent mitochondria as functional units under normal condi-
tions. Thus, future morphology studies aiming to understand
the reshaping of mitochondria under conditions of stress and
disease should aim to combine both assessments of physical
proximity and communication (Glancy et al., 2017; Picard
et al., 2015b), and importantly, to develop quantitative morpho-
logical maps of mitochondrial networks involving the segmenta-
tion of individual mitochondria. A paper using a similar approach
was published while the present article was under review (Bleck
et al., 2018).
An unresolved question in mitochondrial biology is the relation
between respiratory chain dysfunction, mitochondrial elonga-
tion, and fragmentation. Based on in vitro studies, the mitochon-
drial network has been demonstrated to undergo stress-induced
mitochondrial fusion in response to low levels of stress or muta-
tional heteroplasmy (Leduc-Gaudet et al., 2015; Picard et al.,
2014; Shutt and McBride, 2013; Tondera et al., 2009). However,
when mutational heteroplasmy is increased or stress exceeds
some functional threshold, themitochondrial network undergoes
fragmentation. Metabolic challenge, such as starvation, induces
a similar initial pro-fusion response, followed by fragmentation
(Gomes et al., 2011; Rambold et al., 2011). Our data in the
m.8344A>G tRNALys trio lends some support for the validity of
this model in vivo. Both the mother and her affected daughter
with 60%and 97%mutation load, respectively, have fragmented
mitochondrial networks. In comparison, the sister with 40% het-
eroplasmy of the same mutation in fact shows the highest mito-
chondrial network connectivity and number of nanotunnels of all
studied individuals, including controls, consistent with a
compensatory hyperfusion response to low levels of stress.
The current study also demonstrates that the mitochondrial
network is anisotropic. Mitochondrial branching in humans is
approximately four times more extensive across the transverse
z-band than longitudinally. Not only does this reinforce the
notion that three-dimensional assessments of mitochondrial
morphology are more accurate than two-dimensional ones in
muscle samples, but it also has implications for how mtDNA de-
fects spread through muscle fibers. It has long been recognized
that mitochondrial dysfunction is segmental along muscle fibers
(Bua et al., 2006; Elson et al., 2002; Matsuoka et al., 1992)
and expands over time (Lopez et al., 2000). However, anCell Reports 26, 1–14, January 22, 2019 11
Please cite this article in press as: Vincent et al., Quantitative 3D Mapping of the Human Skeletal Muscle Mitochondrial Network, Cell Reports (2019),
https://doi.org/10.1016/j.celrep.2019.01.010understanding of how the spread of mtDNA molecules is
spatially constrained has remained elusive because it is not
currently possible to track this process in real time. If mtDNA de-
fects spread more rapidly along continuous mitochondrial
tubules (i.e., the path of least resistance), our results demon-
strating the anisotropic nature of the mitochondrial network—
with four time more branching transversely than longitudi-
nally—would predict that mitochondrial dysfunction (mtDNA
mutations and respiratory chain deficiency) is likely to propagate
more rapidly in the transverse orientation, rather than longitudi-
nally. Both this finding and the recent identification of early
segments of respiratory chain deficiency that are shorter longitu-
dinally than the diameter of the muscle fiber (Vincent et al., 2018)
converge to suggest that human skeletal muscle mtDNA muta-
tions preferentially spread after following the natural connectivity
of the mitochondrial network. However, given the lack of kinetic
and experimental data, these observations should be interpreted
with caution. In mice, which exhibit more longitudinal columnar
mitochondria and a different and more extensive connectivity
pattern than human mitochondria, the distribution of mtDNA de-
fects and their propagation in disease could follow different ki-
netics and be driven by different mechanisms.
In an effort to identify predictive patterns in our data that would
distinguish healthy individuals from those with mtDNA defects,
we used an integrative machine learning approach. Contrary to
conventional statistical tests that draw inference about a given
sample, machine learning classifiers identify generalizable pre-
dictive patterns from the data (Bzdok et al., 2018). These ap-
proaches are data driven (i.e., do not require prior knowledge
about which measures are more important) and handle datasets
that have a large number of variables relative to the sample size
(Pedro, 2012), such as in this study. We integrated 3D EM data in
multivariate classifiers and discovered that a high prevalence of
simple mitochondria and a high nanotunnel density may be
discriminant morphological features of mitochondrial disease
patients. It could be that these morphological features are spe-
cific to mitochondrial disease, or instead that they represent
more generic morphological changes to energetic stress. A sys-
tematic comparison with non-mitochondrial neuromuscular
disorders would be necessary to establish to what extent this
signature is both sensitive and specific to mtDNA mutations.
Nanotunnels are bacteria-like thin double OMM-IMM mem-
brane connections between mitochondria, capable of transport-
ing proteins between physically constrained mitochondria
(Vincent et al., 2017). Although the link between mtDNA muta-
tions and increased mitochondrial nanotunelling is unclear,
similar to compensatory hyperfusion as an initial stress
response, we speculate that nanotunnels arise from mitochon-
dria under stress that ‘‘reach out for help.’’ In this scenario,
mitochondrial nanotunnels would enable functional complemen-
tation through the diffusion of proteins, ions, transcripts, and
possibly membrane potential between physically constrained
mitochondria that are not close enough to undergo fusion.
Many questions remain unanswered around mitochondrial
nanotunnels including whether their lumen is wide enough to
transport mtDNA packaged as a proteinaceous nucleoids. Our
three-dimensional measurements indicate that only a small
fraction (4.1%) of nanotunnels would be wide enough to accom-12 Cell Reports 26, 1–14, January 22, 2019modate mtDNA nucleoids (based on bovine cryo-EM measure-
ments). Yet, their diffusion or transport would likely require
additional space to enable motility and directional motion within
the nanotunnels. This remains an unresolved point in need of
further investigation.
In conclusion, this work presents a quantitative EM resolution
three-dimensional assessment of mitochondrial morphology
and network organization in human skeletal muscle. This study
also identifies morphological features that distinguish human
from mouse skeletal muscle mitochondria, and healthy individ-
uals from patients with mtDNA mutations, including an elevated
frequency of simple mitochondria and mitochondrial nanotun-
nels in mitochondrial disease. The existence of mitochondrial
nanotunnels suggests a possible mechanism for mitochondrial
communication in human tissues, and a possible disease
marker. Quantitatively defining the 3D morphological and aniso-
tropic characteristics of mitochondrial networks in different
human tissues should yield further insights into the mechanism
underlying the origin and propagation of mitochondrial dysfunc-
tion in aging and disease.
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EXPERIMENTAL MODELS AND SUBJECT DETAILS
Human subjects and patients
This study was approved by the Newcastle and North Tyneside Local Research Ethics Committees (reference 2002/205) and prior
informed consent was obtained from each participant. All experiments were carried out in accordance with the approved guidelines.Cell Reports 26, 1–14.e1–e4, January 22, 2019 e1
Please cite this article in press as: Vincent et al., Quantitative 3D Mapping of the Human Skeletal Muscle Mitochondrial Network, Cell Reports (2019),
https://doi.org/10.1016/j.celrep.2019.01.010Biopsies were obtained from six patients with genetically-confirmedmtDNAdisease; two patients with single, largemtDNAdeletions,
three patients with the m.8344A>G mutation and one with the m.3243A>G mutation (Table S1). In all cases, muscle biopsies were
obtained from the tibialis anterior muscle. A further eight control biopsies from the distal part of the hamstring were collected
from adults undergoing anterior cruciate ligament surgery (Table S2). For both patients and controls a section of the biopsy specimen
was processed for EM, including gentle teasing of small muscle fiber bundles to insure rapid fixation.
Mouse muscle samples
All animal experiments were conducted in compliance with the UK Home Office (PPL 60/4455) and the Newcastle University Animal
Welfare Ethical Review Board. Six male PV-Cre Knockin mice on c57bl/6N background (Jackson lab 008069) aged 5 (n = 2) and 7
(n = 4) months were used for experiments. Pairs of age-matched mice were processed in parallel, one underwent transcardial perfu-
sion and one had a lethal injection of 200 ml of euthatal at 20 mg/mL containing sodium pentobarbital. The transcardially perfused
mice were perfused with 50 mL of EM fixative (2% glutaraldehyde in 0.1M cacodylate buffer), during fixation the hind limb was
attached to a spatula at a right angle preventing unwanted muscle contraction. All mice were dissected and the right tibialis anterior




For all samples, muscle fiber bundles fixed overnight in 2% glutaradehyde (in cacodylate buffer (0.1M, pH7.4)) at 4C. Fibers were
post fixed in 1% osmium tetroxide for 1 hour. Samples were dehydrated in a graded series of acetone (25%, 30 min; 50%, 30 min;
75%, 30 min; 2x100%, 1 hour each) before being impregnated with increasing concentrations of epoxy resin (TAAB medium grade;
25%, 50%, 75% in acetone, 3x100%, all for 1 hour each). They were then embedded in fresh resin and polymerized at 60C for 24-
36 hours. Sections were cut on an ultramicrotome, first semi-thin sections (0.5um) were stained with toluidine blue for LM to identify
the area of interest/confirm orientation of tissue. Ultrathin sections (70nm) were then cut and picked up onto copper grids. Sections
were stained with 1% uranyl acetate (30 min) and 3% lead citrate (7 min) on a Leica EM AC20 automatic staining machine before
being viewed on the TEM (Philips CM100). Images were captured using a CCD camera (AMT40, Deben UK). Scanning for regions
of interest x5800 and initial images were captured at x7900, more detailed images were captured at x13500. Muscle fibers selected
for analysis exhibited no more than two Z-lines separated by a minimum of 10-15 mm, ensuring optimal transverse orientation.
Serial block face scanning electron microscopy
Tissue was fixed in 2% glutaraldehyde in 0.1M cacodylate buffer. It was then processed using a heavy metal protocol adapted from
(Wilke et al., 2013). Tissue was immersed in 3% potassium ferrocyanide + 2% osmium tetroxide (1 hour at 4C), followed by filtered
0.1% thiocarbohydrazide (20 min), then 2% osmium tetroxide (30 min) and finally left overnight in 1% uranyl acetate at 4C (with
several water washes between each step). The next day the samples were immersed in 0.6% lead aspartate solution (30 min at
60C and then dehydrated in graded acetone (as for TEM), impregnated with epoxy Taab 812 hard resin, embedded in fresh resin
and polymerized at 60C for 36-48 hours. After polymerization the block was sectioned for TEM to identify the area of interest
then trimmed to approximately 0.75 mm by 0.5 mm and glued onto an aluminum pin. In order to reduce sample charging within
the SEM, the block was painted with silver glue and sputter-coated with a 5 nm layer of gold. The pin was placed into a Zeiss Sigma
SEM incorporating theGatan 3view system for serial block face (SBF)-SEM, which allows sectioning of the block and the collection of
serial images in the z-direction.
Using Digital Micrograph software, multiple regions of interest were selected and imaged at x8235 magnification, 1024x1024 pixel
scan, which gave a pixel resolution of approximately 10nm. Section thickness was 30nm in the z-direction and at least 400 sections
were collected, yielding a total imaging depth of 12um. Before SBF-SEM, fibers with a high mitochondrial content were selected via
TEM and a z stack then captured. For each human and mouse sample, four cells were imaged including threw for the IMF compart-
ment, and one for the SS/perinuclear compartment.
3D reconstructions
Image stacks from the SBF-SEMwere converted to MRC files and 25 to 50mitochondria reconstructed for each fiber using 3D-MOD
(IMOD image analysis software, (IMOD 4.7, Boulder Laboratory for 3-D Electron Microscopy of Cells). Starting from the center of the
stack to avoid mitochondria that would be interrupted at the edges of the images volume, randomly selected mitochondria were
manually traced using the ‘sculpt’ drawing tool on each section. The OMM of each mitochondrion was followed in all three dimen-
sions. Mitochondria with immediately adjacent OMMwere segmented separately, and membrane continuity was established based
on continuous planar electron density. A mesh and cap was then applied to fully segmented organelles using flat criteria value of 1.5
and all other parameters set as default, which enabled generation of closed volumes for surfaces lying between two 30nm slices in the
Z plane. For each completely reconstructedmitochondrion, the total mesh surface area and total contour volumewere extracted and
used in analyses. SSmitochondria included in quantitative analyses were situated betweenmyofibrils and the sarcolemma, often bute2 Cell Reports 26, 1–14.e1–e4, January 22, 2019
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https://doi.org/10.1016/j.celrep.2019.01.010not always in proximity to a nucleus, and did not protrude into the IMF space. To quantitatively distinguish between the two popu-
lations, SS mitochondria with IMF protrusions, as shown in Video S2, were not included in the analyses.
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantifying mitochondrial complexity








where SA is surface area and V is volume
This equation was derived from form factor (Koopman et al., 2005) and is a three-dimensional equivalent, used to assessmitochon-
drial morphological complexity. The fractional power is necessary to make the overall expression dimensionless (area dimensions of
L2 has dimensions of L3), and thus independent of overall size of the object.
We tested this formula and confirmed that MCI is a measure of mitochondrial complexity invariant to volume (Figure S2). However,
the scaling of MCI did not accurately represent the perceived increase in complexity. Changing the overall power of the complete
expression has the effect of expanding the dynamic range of the measure without changing its dimensionality, and we investigated
the effect of squaring and cubing the total formula. It was observed that squaring themeasure gave themost accurate representation
















Equations (1) and (2) contain the same information, but Equation (2) has a more natural mapping to perceived morphological
difference.
MCI was compared to sphericity, another measure of three-dimensional shape that varies between 0 and 1, which asymptotically
approaches 1 for a perfect sphere. MCI was selected over sphericity due to the theoretically unlimited complexity of mitochondrial
morphology, which can scale up without an upper boundary as morphological complexity increases from sequential fusion events or
increasing numbers of nanotunnels.
Quantifying mitochondrial branching
To assess mitochondrial branching and anisotropy, branching was quantified in the context of the surrounding tissue in the trans-
verse and longitudinal planes and a ratio calculated. For transverse branching index the number of myofibrils bridged was counted
and 1 added. The number of myofibrils bridged was calculated by adding together all branches that added to the distance covered in
the transverse plane. If a branch curved or if the number of myofibrils was greater on one side than the other, the greatest value was
taken (Figure S3A). For longitudinal branching the number of sarcomeres (+2), half sarcomeres (+1) and z-bands (+1) was summed
and 1 added. Again only branches that added to the overall longitudinal distance were included (Figure S3B). The transverse branch-
ing score was divided by the longitudinal branching score, to yield a mitochondrial branching index (MBI). Mitochondrial were clas-
sified into 3 groups based onMBI; > 1 more branched in transverse orientation, 1 equally branched in both orientations and < 1 more
branched longitudinally. Branching quantification was validated by comparison of assessments by two investigators, which yielded
similar proportions of mitochondria established to be either more or equally branched in transverse and longitudinal orientations (Fig-
ure S3C-E). The inter-rater agreement in absolute MBI values was moderate (Figure S3C-E).
Nanotunnel measurements
For the purpose of mitochondrial nanotunnel measurements, previously identified mitochondria with nanotunnels were manually re-
constructed in Microscopy Image Browser (Belevich et al., 2016) and exported as Amira mesh files for measurements analysis
(Cocks et al., 2018). The total number of nanotunnels for whichmeasurements were takenwas 362, some nanotunnels were excluded
from this analysis based morphology which was difficult to measure in Amira. The .mrc image stacks and Amira mesh models were
opened in Amira to derive precise measurements of nanotunnel length, as well as minimum and maximum diameter along the length
each nanotunnel.
Multivariate analysis and machine learning
We calculated summary statistics to describe the observed distributions of mitochondrial volume, complexity (MCI), and number of
nanotunnels in cells from muscle biopsies of human patients, human controls and wild-type mice. Summary statistics included the
percentage of mitochondria whose volume andMCI were in the 10th percentile (bottom 10% of the distribution) or in the 90th percen-
tile (top 10%) of the combined control population (percent large, complex, percent small, and simple, respectively) as well as
the number of nanotunnels per 100 mitochondria and mitochondrial volume density. Partial least-squares discriminant analysisCell Reports 26, 1–14.e1–e4, January 22, 2019 e3
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https://doi.org/10.1016/j.celrep.2019.01.010(PLS-DA) was performed using the mixOmics (6.3.1) (Le^ Cao et al., 2009; Rohart et al., 2017) R (3.4.3) (Team, 2017) package (code
available: https://gist.github.com/CnrLwlss/e4b0b2a2c4290ae4ad4eb9a4373680f3). Variable importance in projection (VIP) scores
were extracted for each mitochondrial feature from PLS-DA models.
Statistical analyses
Data on volume and MCI were fit using a linear mixed model with organism and cell (nested within organism) as random effects and
species/disease status as fixed effects. Because of the extent of the skewness of the data, measurements were log-transformed
before analysis. For all other statistics, normalization was not effective and therefore non-parametric Mann-Whitney tests were
used. For branching analyses a chi square test was used to determine the significance for the percentages of mitochondria classified
in each group.
DATA AND SOFTWARE AVAILABILITY
Image stacks and model files are available from the authors upon request.e4 Cell Reports 26, 1–14.e1–e4, January 22, 2019
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Sex Age at 
biopsy 
 Mitochondrial genetic 
diagnosis 







1 F 62 single, large-scale, mtDNA 
deletion 
34 20 15 CPEO, proximal 
myopathy 
None 
2 F 70 single, large-scale, mtDNA 
deletion 
22 18 9 CPEO and 
myopathy 
None 
3 F 22 m.8344A>G 97 97 10 MERRF Severly affected – 
myopathy   
4 F 50 m.8344A>G 63 22 7 Mild myopathy Mother of patient 3 
5 F 20 m.8344A>G 40 Some COX-
intermediate 
fibres 
0 Asymptomatic Sister of patient 3 
6 F 69 m.3243A>G 21 3 2 MIDD None 
 
% COX deficiency: proportion of myofibers with cytochrome c oxidase deficiency; RRF: ragged red fibers; CPEO: chronic progressive external 
opthalmoplegia; MERRF: myoclonic epilepsy with ragged red fibers; MIDD: Maternally Inherited Deafness and Diabetes. Deletion position and sizes for 















Table S2. Sex and age for healthy control skeletal muscle biopsies from routine anterior cruciate ligament (ACL) surgery. Related 
to STAR methods. 
 
Control ID Sex Age at biopsy 
1 M 23 
2 F 25 
3 M 25 
4 M 27 
5 M 28 
6 M 33 
7 F 35 
























1 2 3 4
Low resolution result:
High resolution result:
1 2 3 4
Accurate segmentation, three 
mitochondria of intermediate length
Inaccurate segmentation, single 
mitochondrion with very high length
Sites of close inter-organellar proximity where lower 
resolution leads to improper segmentation




Figure S1. Method validation by comparison with mice. Related to Figure 1.
(A) Transmission electron micrograph (TEM) of mouse skeletal muscle with columnar inter-myofibrillar (IMF) mitochondria 
that could mistakenly be segmented as a single mitochondrion from images with insufficient resolution.
(B) Results of segmentation of mitochondria in (A) with either high and low resolution imaging. 
(C) Quantification of aspect ratio for mitochondria in (A) and (B). Low resolution imaging leads to overestimation of 
mitochondrial size, length, and branching, and underestimation of mitochondrial numbers. Points are coloured to match 
mitochondria in (A) and (B)
(D) Example reconstruction from high-resolution serial block-face scanning electron microscopy in mouse (left) and image 
stack with adjacent mitochondria appropriately segmented (right).
















Figure S2. Validation of the mitochondrial complexity index (MCI) as a shape descriptor. Related to Figure 2-5.
(A) Three-dimensional shapes (mitochondria) constructed from 1x1x1 blocks for which volume and surface area can be 
determined.
(B) Calculated MCI values for shapes in (A). This analysis confirms that i) MCI is insensitive to volume, as indicated in the 
absence of change in MCI values for the cubes of increasing volumes (Objects 1-3); and ii) MCI is a three-dimensional 
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Figure S3. Quantification of transverse and longitudinal mitochondrial branching to assess anisotropy. 
Related to Figures 1 and 4.
(A) Branching in cross-section is assessed as CBI = 1 + the total length of all branches. The total length of branches 
is the sum of each myofibril “bridged”. In the event that a mitochondrion wraps around one myofibril as depicted the 
side with the greatest value is taken (i.e. this mitochondrion bridges three myofibrils.
(B) Branching in longitudinal orientation is assessed as LBI = 1 + total longitudinal boundaries bridged. Bridging of a 
z-band or half a sarcomere is valued as one, bridging of a full sarcomere is valued as 2.
(C) Inter-rater variability of transverse and (D) longitudinal branching quantification as assessed by comparison of 
investigators 1 and 2 in assessment of mitochondria (n=25 per orientation). 
(E) Classification of mitochondria based on mitochondrial branching index (MBI). MBI = TBI/LBI. Mitochondria are 
classified as; more extensively branched in the transverse orientation (MBI Score >1), equally branched in both 
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Figure S4.  MCI and volume for subsarcolemmal mitochondria in mice, controls and patients. Related to Figures 1 
and 3.
(A) Example three dimensional reconstruction of subsarcolemmal mitochondria (n = 50) from mouse 2, healthy control 
sample 2 and mitochondrial disease patient 3 (m.8344A>G at 97% mutation load). Each mitochondrion is coloured 
differently.
(B) Cumulative frequency distribution for mitochondrial volume in individual mice (orange), healthy controls (blue) and 
mitochondrial disease (green). 
(C) Bar chart showing mean and SEM for mitochondrial complexity index in mice, control humans and mitochondrial 
disease patients.
(D) Cumulative frequency distribution for mitochondrial mitochondrial complexity index in individual mice (orange), healthy 
controls (blue) and mitochondrial disease (green). 
(E) Bar chart showing mean and SEM for mitochondrial complexity index in mice, healthy humans and mitochondrial 
disease.
(F) Log10 volume plotted against Log10 mitochondrial complexity index for each subsarcolemmal mitochondrion from 
combined mice (orange), healthy controls (blue) and mitochondrial disease (green).





Figure S5. Mito-otype of a human muscle fiber. Related to Figure 3.
(A) Standard karyotype for a eukaryotic cell’s chromosomes organized by appearance.
(B) Equivalent organization of 50 individual reconstructed IMF mitochondria from a human muscle fiber organized by 
complexity, from the lowest to the highest MCI (left to right). This mito-otype was generated from the reconstructed muscle 
fiber animated in Video S3, where each mitochondrion can be seen in the context of other mitochondria.


























































































































































Patient 6Pati nt 6
Figure S6.  MCI and volume of controls and patients. Related to Figures 3 and 4.
The z-score for MCI was plotted against the z-score for volume of each mitochondrion. The z-score is the deviation from 
the mean of the healthy control population. Each fibre is plotted in a different colour. These graphs demonstrate that the 
controls generally have a wider range of MCI and volume. In comparison the mitochondrial disease cases have one of 
three patterns of interest. Patients 3 and 4 have a small range of MCI and volume for all fibres. Whereas for patient 2 
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